2,851
edits
SIRT2: Difference between revisions
no edit summary
No edit summary |
|||
| Line 42: | Line 42: | ||
===Development of Drugs Targeting SIRT2=== | ===Development of Drugs Targeting SIRT2=== | ||
The development of drugs targeting SIRT2 is at the frontier of research in aging, neurodegeneration, and cancer. The quest for efficacious and safe modulators of SIRT2 is ongoing, with several candidates in preclinical and clinical trials. Elucidating the structure-activity relationships, optimizing pharmacokinetic properties, and assessing the safety profiles are crucial steps in the development of SIRT2-targeted drugs. These endeavors are aimed at unlocking the therapeutic potential of SIRT2 modulation for various clinical conditions and improving the quality of life for patients suffering from these diseases. | The development of drugs targeting SIRT2 is at the frontier of research in aging, neurodegeneration, and cancer. The quest for efficacious and safe modulators of SIRT2 is ongoing, with several candidates in preclinical and clinical trials. Elucidating the structure-activity relationships, optimizing pharmacokinetic properties, and assessing the safety profiles are crucial steps in the development of SIRT2-targeted drugs. These endeavors are aimed at unlocking the therapeutic potential of SIRT2 modulation for various clinical conditions and improving the quality of life for patients suffering from these diseases. | ||
== See also == | |||
* [[Wikipedia:SIRT2]] | |||
[[Category:Molecular and Cellular Biology]] | |||